252 related articles for article (PubMed ID: 23161620)
21. One-carbon metabolites, B vitamins and associations with systemic inflammation and angiogenesis biomarkers among colorectal cancer patients: results from the ColoCare Study.
Kiblawi R; Holowatyj AN; Gigic B; Brezina S; Geijsen AJMR; Ose J; Lin T; Hardikar S; Himbert C; Warby CA; Böhm J; Bours MJL; van Duijnhoven FJB; Gumpenberger T; Kok DE; Koole JL; van Roekel EH; Schrotz-King P; Ulvik A; Gsur A; Habermann N; Weijenberg MP; Ueland PM; Schneider M; Ulrich A; Ulrich CM; Playdon M
Br J Nutr; 2020 May; 123(10):1187-1200. PubMed ID: 32019627
[TBL] [Abstract][Full Text] [Related]
22. The prognostic value of serum C-reactive protein-bound serum amyloid A in early-stage lung cancer.
Zhang XY; Zhang G; Jiang Y; Liu D; Li MZ; Zhong Q; Zeng SQ; Liu WL; Zeng MS
Chin J Cancer; 2015 Aug; 34(8):335-49. PubMed ID: 26264146
[TBL] [Abstract][Full Text] [Related]
23. Serum amyloid A and C-reactive protein levels and erythrocyte sedimentation rate are important indicators in hidradenitis suppurativa.
Akdogan N; Dogan S; Incel-Uysal P; Karabulut E; Topcuoglu C; Yalcin B; Atakan N
Arch Dermatol Res; 2020 May; 312(4):255-262. PubMed ID: 31729595
[TBL] [Abstract][Full Text] [Related]
24. Circulating C-reactive protein and colorectal cancer risk: a report from the Shanghai Men's Health Study.
Wu J; Cai Q; Li H; Cai H; Gao J; Yang G; Zheng W; Xiang YB; Shu XO
Carcinogenesis; 2013 Dec; 34(12):2799-803. PubMed ID: 23985781
[TBL] [Abstract][Full Text] [Related]
25. Progression of non-small cell lung cancer: diagnostic and prognostic utility of matrix metalloproteinase-2, C-reactive protein and serum amyloid A.
Kanoh Y; Abe T; Masuda N; Akahoshi T
Oncol Rep; 2013 Feb; 29(2):469-73. PubMed ID: 23135313
[TBL] [Abstract][Full Text] [Related]
26. Inflammatory markers and in-hospital mortality in acute ischaemic stroke.
Rallidis LS; Vikelis M; Panagiotakos DB; Rizos I; Zolindaki MG; Kaliva K; Kremastinos DT
Atherosclerosis; 2006 Nov; 189(1):193-7. PubMed ID: 16388807
[TBL] [Abstract][Full Text] [Related]
27. Association of inflammatory markers with colorectal cancer incidence in the atherosclerosis risk in communities study.
Prizment AE; Anderson KE; Visvanathan K; Folsom AR
Cancer Epidemiol Biomarkers Prev; 2011 Feb; 20(2):297-307. PubMed ID: 21217085
[TBL] [Abstract][Full Text] [Related]
28. Association between some inflammatory markers and primary ovarian insufficiency.
Yldrm G; Tokmak A; Kokanal MK; Sarkaya E; Züngün C; İnal HA; Ylmaz FM; Ylmaz N
Menopause; 2015 Sep; 22(9):1000-5. PubMed ID: 25647778
[TBL] [Abstract][Full Text] [Related]
29. C-reactive protein and the risk of incident colorectal cancer.
Erlinger TP; Platz EA; Rifai N; Helzlsouer KJ
JAMA; 2004 Feb; 291(5):585-90. PubMed ID: 14762037
[TBL] [Abstract][Full Text] [Related]
30. C-reactive protein and risk of lung cancer.
Chaturvedi AK; Caporaso NE; Katki HA; Wong HL; Chatterjee N; Pine SR; Chanock SJ; Goedert JJ; Engels EA
J Clin Oncol; 2010 Jun; 28(16):2719-26. PubMed ID: 20421535
[TBL] [Abstract][Full Text] [Related]
31. Sustained low-grade pro-inflammatory state in unmedicated, remitted women with major depressive disorder as evidenced by elevated serum levels of the acute phase proteins C-reactive protein and serum amyloid A.
Kling MA; Alesci S; Csako G; Costello R; Luckenbaugh DA; Bonne O; Duncko R; Drevets WC; Manji HK; Charney DS; Gold PW; Neumeister A
Biol Psychiatry; 2007 Aug; 62(4):309-13. PubMed ID: 17178112
[TBL] [Abstract][Full Text] [Related]
32. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study.
Pradhan AD; Manson JE; Rossouw JE; Siscovick DS; Mouton CP; Rifai N; Wallace RB; Jackson RD; Pettinger MB; Ridker PM
JAMA; 2002 Aug; 288(8):980-7. PubMed ID: 12190368
[TBL] [Abstract][Full Text] [Related]
33. Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro.
Nijsten MW; Olinga P; The TH; de Vries EG; Koops HS; Groothuis GM; Limburg PC; ten Duis HJ; Moshage H; Hoekstra HJ; Bijzet J; Zwaveling JH
Crit Care Med; 2000 Feb; 28(2):458-61. PubMed ID: 10708183
[TBL] [Abstract][Full Text] [Related]
34. Chronic inflammation and risk of colorectal and other obesity-related cancers: The health, aging and body composition study.
Izano M; Wei EK; Tai C; Swede H; Gregorich S; Harris TB; Klepin H; Satterfield S; Murphy R; Newman AB; Rubin SM; Braithwaite D;
Int J Cancer; 2016 Mar; 138(5):1118-28. PubMed ID: 26413860
[TBL] [Abstract][Full Text] [Related]
35. Association of CRP genetic variants with blood concentrations of C-reactive protein and colorectal cancer risk.
Nimptsch K; Aleksandrova K; Boeing H; Janke J; Lee YA; Jenab M; Bueno-de-Mesquita HB; Jansen EH; Tsilidis KK; Trichopoulou A; Weiderpass E; Wu C; Overvad K; Tjønneland A; Boutron-Ruault MC; Dossus L; Racine A; Kaaks R; Canzian F; Lagiou P; Trichopoulos D; Palli D; Agnoli C; Tumino R; Vineis P; Panico S; Johansson A; Van Guelpen B; Khaw KT; Wareham N; Peeters PH; Quirós JR; Venceslá García A; Molina-Montes E; Dorronsoro M; Chirlaque MD; Barricarte Gurrea A; Key TJ; Duarte-Salles T; Stepien M; Gunter MJ; Riboli E; Pischon T
Int J Cancer; 2015 Mar; 136(5):1181-92. PubMed ID: 25043606
[TBL] [Abstract][Full Text] [Related]
36. Body Fatness, Adipose Tissue Compartments, and Biomarkers of Inflammation and Angiogenesis in Colorectal Cancer: The ColoCare Study.
Himbert C; Ose J; Nattenmüller J; Warby CA; Holowatyj AN; Böhm J; Lin T; Haffa M; Gigic B; Hardikar S; Scherer D; Zielske L; Schrotz-King P; Kölsch T; Siegel EM; Shibata D; Ulrich A; Schneider M; Hursting SD; Kauczor HU; Ulrich CM
Cancer Epidemiol Biomarkers Prev; 2019 Jan; 28(1):76-82. PubMed ID: 30333223
[TBL] [Abstract][Full Text] [Related]
37. A prospective study of macrophage inhibitory cytokine-1 (MIC-1/GDF15) and risk of colorectal cancer.
Mehta RS; Song M; Bezawada N; Wu K; Garcia-Albeniz X; Morikawa T; Fuchs CS; Ogino S; Giovannucci EL; Chan AT
J Natl Cancer Inst; 2014 Apr; 106(4):dju016. PubMed ID: 24565956
[TBL] [Abstract][Full Text] [Related]
38. Heart rate variability is independently associated with C-reactive protein but not with Serum amyloid A. The Cardiovascular Risk in Young Finns Study.
Haarala A; Kähönen M; Eklund C; Jylhävä J; Koskinen T; Taittonen L; Huupponen R; Lehtimäki T; Viikari J; Raitakari OT; Hurme M
Eur J Clin Invest; 2011 Sep; 41(9):951-7. PubMed ID: 21323913
[TBL] [Abstract][Full Text] [Related]
39. Comparison of procalcitonin with C-reactive protein and serum amyloid for the early diagnosis of bacterial sepsis in critically ill neonates and children.
Enguix A; Rey C; Concha A; Medina A; Coto D; Diéguez MA
Intensive Care Med; 2001 Jan; 27(1):211-5. PubMed ID: 11280637
[TBL] [Abstract][Full Text] [Related]
40. SAA (Serum Amyloid A): A Novel Predictor of Stroke-Associated Infections.
Schweizer J; Bustamante A; Lapierre-Fétaud V; Faura J; Scherrer N; Azurmendi Gil L; Fluri F; Schütz V; Luft A; Boned S; Sanchez JC; Montaner J; Katan M
Stroke; 2020 Dec; 51(12):3523-3530. PubMed ID: 33161846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
